Pricing Log in Create free account
Saturday 17 October 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

RPRX Healthcare Biotechnology

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024. In the quarter to June 2026, revenue grew 16.5%, EPS fell 40.0%, free cash flow grew 31.6% and total debt rose 12.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

61.29 1.67 +2.80%
Market cap
$34.3B
P/E
42.3×
Fwd P/E
21.9×
Dividend yield
1.51%
F-score
5/9
Altman Z
1.61
Beneish M
−2.83
Dividend safety
37/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Royalty Pharma PLC (RPRX) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Royalty Pharma PLC (RPRX) trades at a P/E ratio of 42.3×. Over the past ten years it has ranged from 12.6× (December 2024) to 493× (January 2023); the current reading is higher than 70% of that period. That is above the Biotechnology industry median of 8.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 28.6× 62.69%
FY2024 17.6× 17.62%
FY2023 15.0× (96.96%)
FY2022 493× 1,160.60%
FY2021 39.1× (5.55%)
FY2020 41.4× (37.81%)
FY2019 66.5× 0.00%
FY2018 66.5× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 38.7× 18.50%
Mar 2026 32.6× 14.01%
Dec 2025 28.6× 7.09%
Sep 2025 26.7× 28.33%
24 more quarters

Against its own ten years

Low 12.6× High 493×
Ten-year median 34.1×
Current reading's percentile 70

P/E ratio against peers

Company P/E ratio
ROIV Roivant Sciences Ltd. compare n/m
BNTX BioNTech SE Sponsored ADR compare n/m
RVMD Revolution Medicines, Inc. compare n/m
INCY Incyte Corporation compare 13.9×
GMAB Genmab A/S Sponsored ADR compare 29.1×
ARGX argenex SE compare 29.6×
ALNY Alnylam Pharmaceuticals, Inc. compare 39.5×
RPRX Royalty Pharma PLC 42.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 62.6×
Biotechnology industry median 8.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on RPRX